K. Stieglitz

发表

Rational Design, Synthesis, and Potency of N‐Substituted Indoles, Pyrroles, and Triarylpyrazoles as Potential Fructose 1,6‐Bisphosphatase Inhibitors

B. Török, A. Rudnitskaya, D. Borkin, 2010, ChemMedChem.

Binding of proteolytically processed phospholipase D from Streptomyces chromofuscus to phosphatidylcholine membranes facilitates vesicle aggregation and fusion.

B. Seaton, M. Roberts, K. Stieglitz, 2001, Biochemistry.

Shape Matters : Improving Docking Results by Prior Analysis of Geometric Attributes of Binding Sites

B. Stec, A. Rudnitskaya, Ken Huynh, 2016 .

Coumarin and Biscoumarin Inhibit in Vitro Obesity Model

M. Choudhary, K. Khan, A. Ejaz, 2016 .

Crystal Structure of a Dual Activity IMPase/FBPase (AF2372) from Archaeoglobus fulgidus

B. Stec, Kenneth A. Johnson, B. Seaton, 2002, The Journal of Biological Chemistry.

Development, risk, and resilience of transgender youth.

K. Stieglitz, 2010, The Journal of the Association of Nurses in AIDS Care : JANAC.

Crystal structure of the tetrameric inositol 1‐phosphate phosphatase (TM1415) from the hyperthermophile, Thermotoga maritima

Weizhong Li, B. Stec, M. Roberts, 2007, The FEBS journal.

Not so clear on oxygen. Comment on Structural basis for cofactor-independent dioxygenation in vancomycin biosynthesis by Widboom et al. (2007), Nature (London), 447, 342-345.

B. Stec, K. Stieglitz, 2008, Acta crystallographica. Section D, Biological crystallography.

The consent process and children.

M. Broome, K. Stieglitz, 1992, Research in nursing & health.

Al-Pillared Ghassoulite Clay as a New Green Catalyst for the Synthesis of Benzothiazoles and Benzimidazoles: Effect of Amine/CEC Ratio

M. Haddad, R. Mamouni, S. Lazar, 2013 .

Novel heteroaromatic organofluorine inhibitors of fructose-1,6-bisphosphatase.

B. Török, A. Rudnitskaya, Ken Huynh, 2009, Journal of medicinal chemistry.

T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.

E. Kantrowitz, J. Eldo, J. Cardia, 2006, Biochemistry.

Identifying New Drug Targets for Potent Phospholipase D Inhibitors: Combining Sequence Alignment, Molecular Docking, and Enzyme Activity/Binding Assays

Weihong Zhou, B. Török, K. Stieglitz, 2016, Chemical biology & drug design.

The Structure of the R184A Mutant of the Inositol Monophosphatase Encoded by suhB and Implications for Its Functional Interactions in Escherichia coli*

D. Court, B. Stec, M. Roberts, 2007, Journal of Biological Chemistry.

Structural Analysis of Flavonoid/Drug Target Complexes: Natural Products as Lead Compounds for Drug Development

K. Stieglitz, Harolin M. Sosa, Yessica J. Sosa, 2017 .

A 20-kDa domain is required for phosphatidic acid-induced allosteric activation of phospholipase D from Streptomyces chromofuscus.

D. Baker, M. Roberts, K. Stieglitz, 1999, Biochimica et biophysica acta.

Comparison of two T-state structures of regulatory-chain mutants of Escherichia coli aspartate transcarbamoylase suggests that His20 and Asp19 modulate the response to heterotropic effectors.

B. Stec, E. Kantrowitz, K. Stieglitz, 2007, Acta crystallographica. Section D, Biological crystallography.

Metal specificity is correlated with two crucial active site residues in Escherichia coli alkaline phosphatase.

E. Kantrowitz, K. Stieglitz, Jie Wang, 2005, Biochemistry.

Bierer agents of the multidrug resistance phenotype Immunosuppressants FK 506 and rapamycin function as reversal

Robert, K. Stieglitz, Arceci, 2003 .

Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype.

B. Bierer, K. Stieglitz, R. Arceci, 1992, Blood.

Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein.

F. Baas, R. Arceci, A. Schinkel, 1993, Cancer research.

The first high pH structure of Escherichia coli aspartate transcarbamoylase

E. Kantrowitz, K. Stieglitz, Jiarong Xia, 2009, Proteins.

1,3‐Disubstituted‐4‐Aminopyrazolo [3, 4‐d] Pyrimidines, a New Class of Potent Inhibitors for Phospholipase D

Phong Quang, Weihong Zhou, B. Török, 2014, Chemical biology & drug design.

Connecting Pathway Errors in the Insulin Signaling Cascade: The Molecular Link to Inflammation, Obesity, Cancer, and Alzheimer’s Disease

K. Stieglitz, Harolin M. Sosa, Yessica J. Sosa, 2020 .

HIV multidisciplinary teams work: Support services improve access to and retention in HIV primary care

S. Shott, R. Sherer, J. Jasek, 2002, AIDS care.

Reaching for mechanistic consensus across life kingdoms: structure and insights into catalysis of the myo-inositol-1-phosphate synthase (mIPS) from Archaeoglobus fulgidus.

B. Stec, M. Roberts, Hongying Yang, 2005, Biochemistry.

Preparation and Implementation of a High Throughput Virtual Screening Protocol on a Shared Memory GPU Supercomputer

Hortensia Gomes Leal, Michelle A. Arya, Richard Anderson, 2021 .

Characterization of recombinant fructose-1,6-bisphosphatase gene mutations: evidence of inhibition/activation of FBPase protein by gene mutation

K. Stieglitz, J. Byron, Victor Epiter-Smith, 2019, Bioscience reports.

Investigation of nepetolide as a novel lead compound: Antioxidant, antimicrobial, cytotoxic, anticancer, anti-inflammatory, analgesic activities and molecular docking evaluation

F. Khan, J. Hussain, Shamsher Ali, 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

The Role of Phospholipase D Enzyme(s) in Modulating Cell Signaling: Implications for Cancer Drug Development

B. Török, K. Stieglitz, Shao-Chung Chang, 2014 .

Monitoring the transition from the T to the R state in E.coli aspartate transcarbamoylase by X-ray crystallography: crystal structures of the E50A mutant enzyme in four distinct allosteric states.

B. Stec, D. Baker, E. Kantrowitz, 2004, Journal of molecular biology.

A single amino acid substitution in the active site of Escherichia coli aspartate transcarbamoylase prevents the allosteric transition.

H. Tsuruta, E. Kantrowitz, K. Stieglitz, 2005, Journal of molecular biology.

240s Loop Interactions Stabilize the T State of Escherichia coli Aspartate Transcarbamoylase*

H. Tsuruta, E. Kantrowitz, S. Gourinath, 2004, Journal of Biological Chemistry.

Structural basis for ordered substrate binding and cooperativity in aspartate transcarbamoylase.

E. Kantrowitz, J. Cardia, K. Stieglitz, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Structure of the E.coli aspartate transcarbamoylase trapped in the middle of the catalytic cycle.

H. Tsuruta, E. Kantrowitz, J. Cardia, 2005, Journal of molecular biology.

Structural Insights for Drugs Developed for Phospholipase D Enzymes.

K. Stieglitz, 2017, Current drug discovery technologies.

B. Stec, B. Seaton, M. Roberts, 2003, Protein science : a publication of the Protein Society.